Pancreatic Cancer Research

ResearcherThomas Jefferson UniversityActive in the last 2 years

Matthias Hebrok

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3833-8862; OpenAlex author ID A5002156552; NIH RePORTER profile ID 6796101. Sources: funder_awards.

Their work

Papers
13 (first author 1, last author 6)
Trials
0
Grants
4
Labs led
1
Collaborators
64
Papers, trials and grants by year

2008: 1 grant · 2009: none · 2010: none · 2011: 1 paper, 1 grant · 2012: 1 paper · 2013: 1 paper · 2014: 2 papers, 1 grant · 2015: 2 papers · 2016: 2 papers · 2017: none · 2018: 1 grant · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 3 papers · 2025: none · 2026: 1 paper

Papers 13

  1. KDM6 Histone Demethylases Tune Pancreatic Cancer Plasticity. Last author DOI 10.1158/0008-5472.can-25-3126↗
  2. Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Co-author DOI 10.1038/s41591-023-02694-w↗
  3. KRAS degradation averts PDAC chemoresistance First author DOI 10.1038/s43018-023-00708-7↗
  4. nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer Last author DOI 10.1101/2024.09.23.614610↗
  5. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Co-author DOI 10.1038/nm.4082↗
  6. PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance. Co-author DOI 10.1101/gad.291021.116↗
  7. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Last author DOI 10.1101/gad.256628.114↗
  8. Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity. Co-author DOI 10.15252/embj.201489574↗
  9. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Last author DOI 10.1038/ncb2916↗
  10. Dicer regulates differentiation and viability during mouse pancreatic cancer initiation. Last author DOI 10.1371/journal.pone.0095486↗
  11. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-12-2067↗
  12. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ccr.2012.10.025↗
  13. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Last author DOI 10.1016/j.ccr.2011.03.002↗

Grants 4

  1. Epigenetic regulation of pancreatic cancer R01CA172045↗
  2. Embryonic signaling pathways in pancreatic cancer R01CA112537↗
  3. Role of miRNAs in Pancreatic Adenocarcinoma AWARD pancan:2011-matthias-hebrok-phd-role-of-mirnas-in-pancreatic-adenocarcin
  4. NF-kB Signaling in PanIN Formation AWARD pancan:2008-matthias-hebrok-phd-nf-kb-signaling-in-panin-formation

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Laura Leonhardt · 3 shared papers, 2016–2026 · strength 0.70
  2. Grace Kim · 7 shared papers, 2011–2026 · strength 0.65
  3. David W. Dawson · 5 shared papers, 2014–2026 · strength 0.48
  4. Valerie Marie Weaver · 3 shared papers, 2016–2024 · strength 0.35
  5. Audrey M. Hendley · 2 shared papers, 2024–2026 · strength 0.35
  6. Nilotpal Roy · 5 shared papers, 2014–2024 · strength 0.33
  7. Eric Andrew Collisson · 3 shared papers, 2015–2024 · strength 0.25
  8. Alex Barrett · 2 shared papers, 2016–2024 · strength 0.20
  9. Hanane Laklai · 2 shared papers, 2016–2024 · strength 0.20
  10. Laura DeLong Wood · 2 shared papers, 2016–2024 · strength 0.20
  11. Raghu Kalluri · 2 shared papers, 2016–2024 · strength 0.20
  12. Harold L. Moses · 2 shared papers, 2016–2024 · strength 0.20
  13. Julia Sidenius Johansen · 2 shared papers, 2016–2024 · strength 0.20
  14. Christine A. Iacobuzio–Donahue · 2 shared papers, 2016–2024 · strength 0.20
  15. Kirk Charles Hansen · 2 shared papers, 2016–2024 · strength 0.20
  16. Giuseppe Malleo · 1 shared paper, 2026 · strength 0.20
  17. Jin Peng He · 1 shared paper, 2026 · strength 0.20
  18. Rondell Patrell Graham · 1 shared paper, 2026 · strength 0.20
  19. Elie M. Ghabi · 1 shared paper, 2026 · strength 0.20
  20. Claudio Luchini · 1 shared paper, 2026 · strength 0.20
  21. David Kuang-Fu Chang · 2 shared papers, 2016–2024 · strength 0.19
  22. Andrew Victor Biankin · 2 shared papers, 2016–2024 · strength 0.19
  23. John P. Morris · 5 shared papers, 2011–2014 · strength 0.16
  24. Guido von Figura · 4 shared papers, 2012–2015 · strength 0.15
  25. Grainne Mary O'Kane · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.